Cellply is a deep tech company with the ambition to develop analytical tools enabling fast end effective development of life-saving cancer cell therapies. Our solutions support biopharma companies and research institutes from discovery to R&D and quality control of advanced therapies. Our team features a unique combination of expertise in a diverse set of technology going from microfluidics to robotics, AI, biology and immunology.
TEAM
Founding team
Massimo Bocchi, PhD
Brought the company from idea to product developed, created the team, raised more than €10m between equity and grants, technology inventor, author of 7 patents, engineering and business background.
Roberto Guerrieri, PhD
Developed core technology, initial team and funding, serial entrepreneur (Silicon Biosystems acquired by Menarini), inventor of fingerprint sensor developed by Upek and acquired by Apple.
Operational team
Massimo Bocchi
CEO and Co-founder
Andrea Faenza
CTO
Laura Rocchi
Head of Biology
Dario Biscarini
Project Manager
Chantal Pozzobon
Office Manager
Francesca Dattolo
Quality Manager
Laura Rambelli
Laboratory and Warehouse Specialist
Rita Ruggiano
Project Leader Analytical SW
Luca Giulianelli
Head of Control SW
Nicola Pecorari
Senior Hardware Engineer
Alice Bettelli
Project Leader Analytical Methods
Silvia Bocchi
Project Leader Assay development
Laura Gruppioni
Junior Software Developer
Nicola Ferroni
Software Developer
Mark Atlas
Marketing and US Sales
INVESTORS
GRANTS & PROJECTS
ONCOSMART
Development of an In-Vitro Diagnostic platform for functional precision medicine to predict the outcome of hematological cancer patients
COVID-19 - Regione ER
Sviluppo di un test prognostico sulla base del profilo immunitario dei pazienti con Coronavirus Disease 19 (COVID-19) ospedalizzati
